Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
A bird's-eye view of T cells during natalizumab therapy.
Rare Inflammatory Diseases of the White Matter and Mimics of Multiple Sclerosis and Related Disorders.
Treatment of Multiple Sclerosis With Chinese Scalp Acupuncture.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Microglia: Architects of the Developing Nervous System.
Diagnosis and treatment of pediatric acute transverse myelitis.
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
The Communicative Participation Item Bank (CPIB): Item bank calibration and development of a disorder-generic short form.
Pages
« first
‹ previous
…
236
237
238
239
240
241
242
243
244
…
next ›
last »